Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Mar 21, 2024

BUY
$37.55 - $62.64 $1.54 Million - $2.56 Million
40,928 Added 674.04%
47,000 $2.94 Million
Q3 2023

Nov 13, 2023

BUY
$43.4 - $62.52 $263,524 - $379,621
6,072 New
6,072 $268,000
Q4 2022

Feb 13, 2023

SELL
$34.17 - $47.91 $361,791 - $507,271
-10,588 Reduced 85.77%
1,756 $70,000
Q3 2022

Nov 14, 2022

BUY
$36.93 - $56.68 $455,863 - $699,657
12,344 New
12,344 $541,000
Q2 2022

Aug 11, 2022

SELL
$28.13 - $44.54 $4.05 Million - $6.42 Million
-144,100 Closed
0 $0
Q1 2022

May 12, 2022

BUY
$30.32 - $91.33 $4.37 Million - $13.2 Million
144,100 New
144,100 $5.86 Million
Q1 2020

May 13, 2020

SELL
$17.27 - $40.17 $708,070 - $1.65 Million
-41,000 Closed
0 $0
Q4 2019

Feb 12, 2020

BUY
$32.1 - $40.4 $1.32 Million - $1.66 Million
41,000 New
41,000 $1.38 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.3B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Healthcare Of Ontario Pension Plan Trust Fund Portfolio

Follow Healthcare Of Ontario Pension Plan Trust Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Healthcare Of Ontario Pension Plan Trust Fund, based on Form 13F filings with the SEC.

News

Stay updated on Healthcare Of Ontario Pension Plan Trust Fund with notifications on news.